|
IQVIA™ Real-World Insights Bibliography
| Infliximab Drug and Infusion Costs Among Patients with Crohn's Disease IN a Commercially-Insured Setting. |
| Author(s): Ollendorf DA, Lidsky L. |
| Affiliations(s): |
Publication(s): American Journal OF Therapeutics 2006;13:502-506.
|
| Document Type(s): Manuscript in preparation, |
| Countries: USA, |
C:
Y: |
Gastrointestinal disorders,
2006 |
|
L:
A: |
English
|
|
 |
| |
| |
| The Current and Future Burden and Cost of Overactive Bladder in Five European Countries. |
| Author(s): Reeves P1, Irwin D2, Kelleher C3, Milsom I4, Kopp Z5, Calvert N1, Lloyd A1. |
| Affiliations(s): 1 Fourth Hurdle Consulting, London, UK 2 Dept of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC,US 3 Dept of Obstetrics and Gynaecology, Guy's and St Thomas' NHS Trust, London, UK 4 Dept of Obstetrics and Gynecology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden 5 Pfizer Inc., New York, US |
Publication(s): European Urology 2006; 50(5): 1050-1057
|
| Document Type(s): Manuscript in preparation, |
| Countries: Germany, Italy, Spain, Sweden, UK, |
C:
Y: |
Gastrointestinal disorders,
2006 |
|
L:
A: |
English
Cost of illness, |
|
|
| |
| |
| Clinical Practice Guideline for irritable bowel syndrome |
| Author(s): Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J |
| Affiliations(s): |
Publication(s): Gastroenterol Hepatol. 2006;29(8):467-521
|
| Document Type(s): Article, |
| Countries: Spain, |
C:
Y: |
Gastrointestinal disorders,
2006 |
|
L:
A: |
Spanish
Methodology, |
|
|
| |
| |
| Infliximab Drug and Infusion Costs Among Patients with Crohn?s Disease in a Commercially-Insured Setting. |
| Author(s): Ollendorf D, Lidsky L |
| Affiliations(s): |
Publication(s): American Journal of Therapeutics, 2006, 13(6): 502-506
|
| Document Type(s): Article, |
| Countries: USA, |
C:
Y: |
Gastrointestinal disorders,
2006 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
 11 of 11
|
|
